Somatic mutation of fibroblast growth factor receptor-3 (FGFR3) defines a distinct morphological subtype of high-grade urothelial carcinoma.

MLA

Al-Ahmadie, Hikmat A., et al. “Somatic Mutation of Fibroblast Growth Factor Receptor-3 (FGFR3) Defines a Distinct Morphological Subtype of High-Grade Urothelial Carcinoma.” The Journal of Pathology, vol. 224, no. 2, June 2011, pp. 270–79. EBSCOhost, https://doi.org/10.1002/path.2892.

APA

Al-Ahmadie, H. A., Iyer, G., Janakiraman, M., Lin, O., Heguy, A., Tickoo, S. K., Fine, S. W., Gopalan, A., Chen, Y., Balar, A., Riches, J., Bochner, B., Dalbagni, G., Bajorin, D. F., Reuter, V. E., Milowsky, M. I., & Solit, D. B. (2011). Somatic mutation of fibroblast growth factor receptor-3 (FGFR3) defines a distinct morphological subtype of high-grade urothelial carcinoma. The Journal of Pathology, 224(2), 270–279. https://doi.org/10.1002/path.2892

Chicago

Al-Ahmadie, Hikmat A, Gopa Iyer, Manickam Janakiraman, Oscar Lin, Adriana Heguy, Satish K Tickoo, Samson W Fine, et al. 2011. “Somatic Mutation of Fibroblast Growth Factor Receptor-3 (FGFR3) Defines a Distinct Morphological Subtype of High-Grade Urothelial Carcinoma.” The Journal of Pathology 224 (2): 270–79. doi:10.1002/path.2892.